Summary of Research: Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis. - Vu, Tuan; Meisel, Andreas; Mantegazza, Renato; Annane, Djillali; Katsuno, Masahisa; Aguzzi, Rasha; Enayetallah, Ahmed; Beasley, Kathleen N.; Rampal, Nishi; Howard Jr., James F. (Neurology & Therapy, 2023)